2016Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhiRequires access

Long-term outcomes and prognostic factors of surgical resection of hilar cholangiocarcinoma

Xiaoyu Yin, Xin Liu, Wei Chen, Jian‐Peng Cai, Dong Chen, Kunsong Zhang, Jiaming Lai

Open publisher page 1 citations

Abstract

Objective To investigate the long-term outcomes and prognostic factors of surgical resection of hilar cholangiocarcinoma. Methods The retrospective case-control study was adopted. The clinicopathological data of 129 patients with hilar cholangiocarcinoma who underwent surgery at the First Affiliated Hospital of Sun Yat-sen University between January 2007 and August 2014 were collected. The follow-up of outpatient examination and telephone interview was performed to observe the survival of patients, tumor recurrence and metastasis up to October 2015. (1) Long-term outcomes (1-, 3-, 5-year survival rates and survival time) were observed. (2) Prognostic factors were collected, including gender, age, preoperative CA19-9, tumor diameter, curative degree of tumor (R0 resection or R1 resection), vascular resection and reconstruction, modified T stage, lymph node metastasis, TNM stage and tumor differentiation. (3) The stratified analyses were used for the independent prognostic factors. The survival curve was drawn by Kaplan-Meier method, and the survival rate was analyzed using the Log-rank test. The univariate analysis and multivariate analysis were respectively done using the chi-square test and COX regression model. Results (1) Of 129 patients, 4 patients were dead in the perioperative period, 112 were followed up for a median time of 19 months (range, 1-98 months). During the follow-up, 75 patients were dead. The overall median survival time and 1-, 3-, 5-year survival rates of the 129 patients were 23 months, 71.1%, 31.4% and 14.6%, respectively. (2) The results of univariate analysis showed that curative degree of tumor, modified T stage, lymph node metastasis, TNM stage and tumor differentiation were the related factors affecting the prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma (χ2=5.566, 5.450, 4.558, 4.033, 6.093, P<0.05). The results of multivariate analysis showed that R1 resection, stage Ⅲ-Ⅳ and low-differentiated tumor were the independent risk factors affecting the poor prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma (HR=2.328, 1.691, 1.750, 95% confidence interval: 1.224-4.427, 1.035-2.762, 1.205-2.542, P<0.05). (3) The median survival time and 1-, 3-, 5-year survival rates were 24 months, 75.5%, 36.0% , 15.8% in 110 patients with R0 resection, the median survival time and 1-, 3-year survival rates were 12 months, 47.1% and 7.1% and the 5-year survival rate missed in the 19 patients with R1 resection, with a statistically significant difference (χ2=5.566, P<0.05). The median survival time and 1-, 3-, 5-year survival rates were 30 months, 75.0%, 42.5%, 20.1% in 55 patients with stageⅠ-Ⅱ and 18 months, 68.1%, 22.2%, 7.0% in 74 patients with stage Ⅲ-Ⅳ, respectively, showing a statistically significant difference (χ2=4.033, P<0.05). The median survival time and 1-, 3-, 5-year survival rates were 30 months, 82.4%, 49.5%, 49.5% in 19 patients with high-differentiated tumor, 24 months, 69.6%, 30.4%, 11.8% in 62 patients with moderate-differentiated tumor, 18 months, 63.5%, 24.2%, 0.0 in 33 patients with low-differentiated tumor, respectively, with a statistically significant difference (χ2=6.093, P<0.05). Conclusions Long-term outcomes of surgical resection of hilar cholangiocarcinoma are unsatisfactory. Moreover, R1 resection, stage Ⅲ-Ⅳ and low-differentiated tumor are the independent risk factors affecting the poor prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma. Key words: Biliary tract neoplasms, hilar; Surgical resection; Prognostic factors

About this research paper

What this paper is about

Objective To investigate the long-term outcomes and prognostic factors of surgical resection of hilar cholangiocarcinoma. Methods The retrospective case-control study was adopted. The clinicopathological data of 129 patients with hilar cholangiocarcinoma who underwent surgery at the First Affiliated Hospital of Sun Yat-sen University between January 2007 and August 2014 were collected. The follow-up of outpatient examination and telephone interview was performed to observe the survival of patients, tumor recurrence and metastasis up to October 2015. (1) Long-term outcomes (1-, 3-, 5-year survival rates and survival time) were observed. (2) Prognostic factors were collected, including gender, age, preoperative CA19-9, tumor diameter, curative degree of tumor (R0 resection or R1 resection), vascular resection and reconstruction, modified T stage, lymph node metastasis, TNM stage and tumor differentiation. (3) The stratified analyses were used for the independent prognostic factors. The survival curve was drawn by Kaplan-Meier method, and the survival rate was analyzed using the Log-rank test. The univariate analysis and multivariate analysis were respectively done using the chi-square test and COX regression model. Results (1) Of 129 patients, 4 patients were dead in the perioperative period, 112 were followed up for a median time of 19 months (range, 1-98 months). During the follow-up, 75 patients were dead. The overall median survival time and 1-, 3-, 5-year survival rates of the 129 patients were 23 months, 71.1%, 31.4% and 14.6%, respectively. (2) The results of univariate analysis showed that curative degree of tumor, modified T stage, lymph node metastasis, TNM stage and tumor differentiation were the related factors affecting the prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma (χ2=5.566, 5.450, 4.558, 4.033, 6.093, P<0.05). The results of multivariate analysis showed that R1 resection, stage Ⅲ-Ⅳ and low-differentiated tumor were the independent risk factors affecting the poor prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma (HR=2.328, 1.691, 1.750, 95% confidence interval: 1.224-4.427, 1.035-2.762, 1.205-2.542, P<0.05). (3) The median survival time and 1-, 3-, 5-year survival rates were 24 months, 75.5%, 36.0% , 15.8% in 110 patients with R0 resection, the median survival time and 1-, 3-year survival rates were 12 months, 47.1% and 7.1% and the 5-year survival rate missed in the 19 patients with R1 resection, with a statistically significant difference (χ2=5.566, P<0.05). The median survival time and 1-, 3-, 5-year survival rates were 30 months, 75.0%, 42.5%, 20.1% in 55 patients with stageⅠ-Ⅱ and 18 months, 68.1%, 22.2%, 7.0% in 74 patients with stage Ⅲ-Ⅳ, respectively, showing a statistically significant difference (χ2=4.033, P<0.05). The median survival time and 1-, 3-, 5-year survival rates were 30 months, 82.4%, 49.5%, 49.5% in 19 patients with high-differentiated tumor, 24 months, 69.6%, 30.4%, 11.8% in 62 patients with moderate-differentiated tumor, 18 months, 63.5%, 24.2%, 0.0 in 33 patients with low-differentiated tumor, respectively, with a statistically significant difference (χ2=6.093, P<0.05). Conclusions Long-term outcomes of surgical resection of hilar cholangiocarcinoma are unsatisfactory. Moreover, R1 resection, stage Ⅲ-Ⅳ and low-differentiated tumor are the independent risk factors affecting the poor prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma. Key words: Biliary tract neoplasms, hilar; Surgical resection; Prognostic factors

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the long-term outcomes and prognostic factors of surgical resection of hilar cholangiocarcinoma. Methods The retrospective case-control study was adopted. The clinicopathological data of 129 patients with hilar cholangiocarcinoma who underwent surgery at the First Affiliated Hospital of Sun Yat-sen University between January 2007 and August 2014 were collected. The follow-up of outpatient examination and telephone interview was performed to observe the survival of patients, tumor recurrence and metastasis up to October 2015. (1) Long-term outcomes (1-, 3-, 5-year survival rates and survival time) were observed. (2) Prognostic factors were collected, including gender, age, preoperative CA19-9, tumor diameter, curative degree of tumor (R0 resection or R1 resection), vascular resection and reconstruction, modified T stage, lymph node metastasis, TNM stage and tumor differentiation. (3) The stratified analyses were used for the independent prognostic factors. The survival curve was drawn by Kaplan-Meier method, and the survival rate was analyzed using the Log-rank test. The univariate analysis and multivariate analysis were respectively done using the chi-square test and COX regression model. Results (1) Of 129 patients, 4 patients were dead in the perioperative period, 112 were followed up for a median time of 19 months (range, 1-98 months). During the follow-up, 75 patients were dead. The overall median survival time and 1-, 3-, 5-year survival rates of the 129 patients were 23 months, 71.1%, 31.4% and 14.6%, respectively. (2) The results of univariate analysis showed that curative degree of tumor, modified T stage, lymph node metastasis, TNM stage and tumor differentiation were the related factors affecting the prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma (χ2=5.566, 5.450, 4.558, 4.033, 6.093, P<0.05). The results of multivariate analysis showed that R1 resection, stage Ⅲ-Ⅳ and low-differentiated tumor were the independent risk factors affecting the poor prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma (HR=2.328, 1.691, 1.750, 95% confidence interval: 1.224-4.427, 1.035-2.762, 1.205-2.542, P<0.05). (3) The median survival time and 1-, 3-, 5-year survival rates were 24 months, 75.5%, 36.0% , 15.8% in 110 patients with R0 resection, the median survival time and 1-, 3-year survival rates were 12 months, 47.1% and 7.1% and the 5-year survival rate missed in the 19 patients with R1 resection, with a statistically significant difference (χ2=5.566, P<0.05). The median survival time and 1-, 3-, 5-year survival rates were 30 months, 75.0%, 42.5%, 20.1% in 55 patients with stageⅠ-Ⅱ and 18 months, 68.1%, 22.2%, 7.0% in 74 patients with stage Ⅲ-Ⅳ, respectively, showing a statistically significant difference (χ2=4.033, P<0.05). The median survival time and 1-, 3-, 5-year survival rates were 30 months, 82.4%, 49.5%, 49.5% in 19 patients with high-differentiated tumor, 24 months, 69.6%, 30.4%, 11.8% in 62 patients with moderate-differentiated tumor, 18 months, 63.5%, 24.2%, 0.0 in 33 patients with low-differentiated tumor, respectively, with a statistically significant difference (χ2=6.093, P<0.05). Conclusions Long-term outcomes of surgical resection of hilar cholangiocarcinoma are unsatisfactory. Moreover, R1 resection, stage Ⅲ-Ⅳ and low-differentiated tumor are the independent risk factors affecting the poor prognosis of patients undergoing surgical resection of hilar cholangiocarcinoma. Key words: Biliary tract neoplasms, hilar; Surgical resection; Prognostic factors

Key concepts: Medicine, Univariate analysis, Proportional hazards model, Survival analysis, Stage (stratigraphy), Perioperative, Surgery, Survival rate

Related papers

Back to paper searchBrowse research topicsOriginal source
Long-term outcomes and prognostic factors of surgical resection of hilar cholangiocarcinoma — Research Paper | ScholarLens